GSA Capital Partners »

BioCryst Pharmaceuticals shares owned by GSA Capital Partners

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2011-12-31 $28k 11k 2.50

More positions owned by GSA Capital Partners

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Global Ship Lease Com Cl A (GSL)
Staar Surgical Com Par $0.01 (STAA)
Progressive Corporation (PGR)
Accenture Plc Ireland Shs Class A (ACN)
Star Bulk Carriers Corp. Shs Par (SBLK)
Teck Resources CL B (TECK)
Vital Farms (VITL)
TJX Companies (TJX)
Fresh Del Monte Produce Ord (FDP)
Magnite Ord (MGNI)
Comcast Corp Cl A (CMCSA)

View all positions for GSA Capital Partners

Top funds holding BioCryst Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding BioCryst Pharmaceuticals